Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2020-07-01
2027-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
NCT03803735
Impact of Tumour 1q Gain in French Pediatric and Young Adult Patients With Renal Tumours
NCT04005820
Ureteropelvic Junction Obstruction in Early Childhood: Comparison of Surgical Therapy and Surveillance. A Prospective, Randomized, Controlled Multi-Center Study
NCT00444431
Multi-Centre Gastroschisis Interventional Study Across Sub-Saharan Africa
NCT03724214
Prevention of Renal Failure in Children With Urinary Tract Infections
NCT00316043
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with Nephroblastoma
All children coming into the participating units with suspected Nephroblastoma.
Data collection
Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
.
Exclusion Criteria
6 Months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Africa Pediatric Oncology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatou Binetou Ms DIAGNE AKONDE, Dr
Role: PRINCIPAL_INVESTIGATOR
French Africa Pediatric Oncology Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou, , Burkina Faso
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District, Côte d’Ivoire
CUK (Cliniques Universitaires de Kinshasa)
Kinshasa, , Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, , Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, , Madagascar
CHU Gabriel Touré (HGT)
Bamako, , Mali
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Dakar, Senegal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sonia Ms Kaboret, Dr
Role: primary
[email protected]
Role: backup
Line Guei COUITCHERE, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFANEPHRO2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.